Latest Advances

  • Condition: Relapsed/Refractory Large B-Cell Lymphoma (LBCL)
  • Journal: Blood advances
  • Treatment Used: Lisocabtagene Maraleucel
  • Published —
This study determined the effect of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma (LBCL).
  • Condition: High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
  • Journal: Blood advances
  • Treatment Used: Prophylactic High-Dose Methotrexate (HD-MTX)
  • Number of Patients: 258
  • Published —
This study evaluated the safety and effectiveness of prophylactic high-dose methotrexate (chemotherapy agent and immune-system suppressant; HD-MTX) in high-risk diffuse large B-cell lymphoma (cancer of B cells; DLBCL).
  • Condition: Aggressive B-Cell Lymphoma and Acute Lymphoblastic Leukemia
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: CAR-T Cell Therapy
  • Number of Patients: 0
  • Published —
This article discusses the outpatient administration of CAR-T cell therapy for the treatment of patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia.
  • Condition: Diffuse Large B-Cell Non-Hodgkin Lymphoma (DLBCL)
  • Journal: JCO global oncology
  • Treatment Used: CNS Prophylaxis Strategies
  • Number of Patients: 110
  • Published —
This study presented data on primary central nervous system (CNS) prophylaxis strategy for patients with diffuse large B-cell lymphoma (DLBCL).
  • Condition: Japanese Patients with Non-Hodgkin B-Cell Lymphoma
  • Journal: BMC cancer
  • Treatment Used: Granulocyte Colony-Stimulating Factor (G-CSF)
  • Number of Patients: 234
  • Published —
This study analyzed background factors for granulocyte colony-stimulating factor (G-CSF) preparation selection for febrile neutropenia (FN) prophylaxis in Japanese patients with non-Hodgkin B-cell lymphoma.
  • Condition: Helicobacter Pylori-Independent Gastric MALT Lymphoma
  • Journal: Blood advances
  • Treatment Used: Involved-Site Radiotherapy (RT)
  • Number of Patients: 178
  • Published —
This study investigated the safety and effectiveness of radiation therapy (RT) in the treatment of patients with Helicobacter pylori-independent gastric mucosa-associated lymphoid tissue (MALT) lymphoma (GML).
  • Condition: Peripheral T-Cell Lymphomas
  • Journal: Cell transplantation
  • Treatment Used: Myeloablative Haploidentical Transplant
  • Number of Patients: 52
  • Published —
This study investigated the use of myeloablative haploidentical transplant as an alternative to matched sibling transplant for peripheral T-cell lymphomas.
  • Condition: Primary Hepatic Extranodal Marginal Zone B-Cell Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
  • Journal: The Journal of international medical research
  • Treatment Used: Radiofrequency Ablation (RFA)
  • Number of Patients: 1
  • Published —
This case report describes a 63-year-old woman diagnosed with primary hepatic extranodal marginal zone B-cell mucosa-associated lymphoid tissue (MALT) lymphoma treated with radiofrequency ablation (RFA).
Showing 1-12 of 385